Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Keratin 20 (KRT20) antibody

Antigen

Keratin 20 (KRT20)

Synonyms K20, CD20, CK20, KRT21, MGC35423, 9030623C06Rik, Krt21, KRT20, MGC152269
Clonality Monoclonal (KS20-5)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human, Pig (Porcine)

Conjugate
Alternatives Un-conjugated
Application
Alternatives Immunohistochemistry (Frozen Sections) (IHC (fro)), Western Blotting (WB)
7 references available
Catalog no. ABIN125990
Quantity 50 µg
Price 528.00 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 6 to 8 Business Days

Additional Information

Alternative name Cytokeratin 20
UniProt P35900
Immunogen Electrophoretically purified keratin K20 from human intestinal mucosa.
Cross-Reactivity Human, Pig (Porcine)
Isotype IgG2a
Clone KS20-5
Description Cytokeratin 20 is a type I keratin which is primarily expressed in gastric and intestinalepithelium, urothelium, and Merkel-cells. The keratins are intermediate filament proteinsresponsible for the structural integrity of epithelial cells and are subdivided intocytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which arearranged in pairs of heterotypic keratin chains. Their genes are clustered in a region ofchromosome 17q12-q21. Cytokeratin 20 is a major cellular protein of mature enterocytesand goblet cells and is specifically expressed in the gastric and intestinal mucosa. It isalso expressed in adenocarcinomas of the colon, stomach, pancreas and the bile systemand is present in mucinous ovarian tumors, transitional-cell and Merkel-cell carcinomas. Notably, the squamous cell carcinomas and adenocarcinomas of the breast, lung, andendometrium, non-mucinous tumors of the ovary, and small cell carcinomas lackcytokeratin 20.
Characteristics Synonyms: Cytokeratin 20, Keratin-20, KRT20, CK20, K20, Protein IT, Keratin type I cytoskeletal 20

Application Details

Application Notes Immunohistochemical on frozen sections: 1: 10, 1h at RT or over night at 2-8C. Immunohistochemical on cytological material. Immunoblotting. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Purification Purified
Buffer PBS buffer, pH 7.4 containing 0.09 % sodium azide, 0.5% BSAReconstitution: Restore in 1 ml dist. water
Storage Prior to reconstitution store at 2-8°C. Following reconstitution store the antibody at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Research Area Signaling, Cytoskeleton, Cytokeratins, Extracellular Matrix, Cancer
Restrictions For Research Use only

Publications

Moll, Loewe, Laufer et al.: "Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies." in: The American journal of pathology, Vol. 140, Issue 2, pp. 427-47, 1992 (PubMed).

Moll, Schiller, Franke: "Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns." in: The Journal of cell biology, Vol. 111, Issue 2, pp. 567-80, 1990 (PubMed).

Moll, Moll: "Comparative cytokeratin analysis of sweat gland ducts and eccrine poromas." in: Archives of dermatological research, Vol. 283, Issue 5, pp. 300-9, 1991 (PubMed).

Moebus, Moll, Gerharz et al.: "Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis." in: British journal of cancer, Vol. 69, Issue 3, pp. 422-8, 1994 (PubMed).

Moll, Zimbelmann, Goldschmidt et al.: "The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas." in: Differentiation; research in biological diversity, Vol. 53, Issue 2, pp. 75-93, 1993 (PubMed).

Demirkesen, Hoede, Moll: "Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins." in: Journal of cutaneous pathology, Vol. 22, Issue 6, pp. 518-35, 1996 (PubMed).

Harnden, Eardley, Joyce et al.: "Cytokeratin 20 as an objective marker of urothelial dysplasia." in: British journal of urology, Vol. 78, Issue 6, pp. 870-5, 1997 (PubMed).